BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 30305500)

  • 1. [Molecular pathophysiology of sideroblastic anemia].
    Fujiwara T
    Rinsho Ketsueki; 2018; 59(10):1979-1987. PubMed ID: 30305500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology and genetic mutations in congenital sideroblastic anemia.
    Fujiwara T; Harigae H
    Pediatr Int; 2013 Dec; 55(6):675-9. PubMed ID: 24003969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathophysiology and genetic mutations in congenital sideroblastic anemia.
    Fujiwara T; Harigae H
    Free Radic Biol Med; 2019 Mar; 133():179-185. PubMed ID: 30098397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ring sideroblasts and iron metabolism].
    Fujiwara T
    Rinsho Ketsueki; 2020; 61(7):770-778. PubMed ID: 32759564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent advances in the knowledge of sideroblastic anemia].
    Fujiwara T
    Rinsho Ketsueki; 2022; 63(6):600-607. PubMed ID: 35831194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biology of sideroblastic anemia].
    Harigae H
    Rinsho Ketsueki; 2017; 58(4):347-352. PubMed ID: 28484165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sideroblastic anemia].
    Fujiwara T
    Rinsho Ketsueki; 2019; 60(5):408-416. PubMed ID: 31168006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary sideroblastic anemia: pathophysiology and gene mutations.
    Harigae H; Furuyama K
    Int J Hematol; 2010 Oct; 92(3):425-31. PubMed ID: 20848343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New mutation in erythroid-specific delta-aminolevulinate synthase as the cause of X-linked sideroblastic anemia responsive to pyridoxine.
    Kucerova J; Horvathova M; Mojzikova R; Belohlavkova P; Cermak J; Divoky V
    Acta Haematol; 2011; 125(4):193-7. PubMed ID: 21252495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary sideroblastic anemias: pathophysiology, diagnosis, and treatment.
    Camaschella C
    Semin Hematol; 2009 Oct; 46(4):371-7. PubMed ID: 19786205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and genetic characteristics of congenital sideroblastic anemia: comparison with myelodysplastic syndrome with ring sideroblast (MDS-RS).
    Ohba R; Furuyama K; Yoshida K; Fujiwara T; Fukuhara N; Onishi Y; Manabe A; Ito E; Ozawa K; Kojima S; Ogawa S; Harigae H
    Ann Hematol; 2013 Jan; 92(1):1-9. PubMed ID: 22983749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial iron metabolism and sideroblastic anemia.
    Sheftel AD; Richardson DR; Prchal J; Ponka P
    Acta Haematol; 2009; 122(2-3):120-33. PubMed ID: 19907149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 5-aminolevulinic acid on erythropoiesis: a preclinical in vitro characterization for the treatment of congenital sideroblastic anemia.
    Fujiwara T; Okamoto K; Niikuni R; Takahashi K; Okitsu Y; Fukuhara N; Onishi Y; Ishizawa K; Ichinohasama R; Nakamura Y; Nakajima M; Tanaka T; Harigae H
    Biochem Biophys Res Commun; 2014 Nov; 454(1):102-8. PubMed ID: 25450364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical features and gene mutation spectrum in children with sideroblastic anemia].
    An WB; An WB; Liu C; Wan Y; Guo Y; Wang SC; Zhang YC; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 Oct; 21(10):1016-1021. PubMed ID: 31642437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and Molecular Characterization of Human Ring Sideroblasts: a Key Role of Ferrous Iron in Terminal Erythroid Differentiation and Ring Sideroblast Formation.
    Saito K; Fujiwara T; Hatta S; Morita M; Ono K; Suzuki C; Fukuhara N; Onishi Y; Nakamura Y; Kawamata S; Shimizu R; Yamamoto M; Harigae H
    Mol Cell Biol; 2019 Apr; 39(7):. PubMed ID: 30670569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.
    Cotter PD; May A; Fitzsimons EJ; Houston T; Woodcock BE; al-Sabah AI; Wong L; Bishop DF
    J Clin Invest; 1995 Oct; 96(4):2090-6. PubMed ID: 7560104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias.
    Peoc'h K; Nicolas G; Schmitt C; Mirmiran A; Daher R; Lefebvre T; Gouya L; Karim Z; Puy H
    Mol Genet Metab; 2019 Nov; 128(3):190-197. PubMed ID: 30737140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel g.55040074delT in ALAS2 Gene Resulting in a Monomeric Protein and Severe Sideroblastic Anemia Phenotype.
    Bhatia P; Singh A; Hedge A
    J Pediatr Hematol Oncol; 2017 Aug; 39(6):463-465. PubMed ID: 28731922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital sideroblastic anemia model due to ALAS2 mutation is susceptible to ferroptosis.
    Ono K; Fujiwara T; Saito K; Nishizawa H; Takahashi N; Suzuki C; Ochi T; Kato H; Ishii Y; Onodera K; Ichikawa S; Fukuhara N; Onishi Y; Yokoyama H; Yamada R; Nakamura Y; Igarashi K; Harigae H
    Sci Rep; 2022 May; 12(1):9024. PubMed ID: 35637209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic molecular genetic analysis of congenital sideroblastic anemia: evidence for genetic heterogeneity and identification of novel mutations.
    Bergmann AK; Campagna DR; McLoughlin EM; Agarwal S; Fleming MD; Bottomley SS; Neufeld EJ
    Pediatr Blood Cancer; 2010 Feb; 54(2):273-8. PubMed ID: 19731322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.